Philippos patsalis biography of william

Serves on international scientific and business boards, committees and councils. Based in Cyprus. Clinical geneticist and genetic counsellor, with a special emphasis on rare hereditary diseases and analysis of NGS data. Based in Munich, Germany. Clinical laboratory and human geneticist, with 30 years of experience in human genetics with a special emphasis on prenatal genetic diagnostics and non invasive prenatal testing.

Heading the laboratory operations in Berlin, Germany. Biochemist and biotechnology engineer, working in clinical diagnostics with an emphasis on B2B and B2C global sales strategies. Molecular geneticist and researcher, with a special emphasis on genomics, epigenetics, and non-invasive diagnostics. Overseeing all research activities including product development, technology optimization.

Clinical laboratory and molecular geneticist, with extensive experience in molecular and genomics technologies and over 10 years of leading a genetic testing laboratory. Board certified by the American Society of Clinical Pathologists. Expert in business automations and design of digital systems, with a wealth of experience in providing strategic consulting services to large organizations.

Philippos patsalis biography of william

Worked with various sectors and institutions in Europe and the Middle East. Member of the PMI. Motivational sales leader with a background in genetic sciences. Over 15 years of commercial experience leading successfully specialist and regional teams, developing strategic partnerships and sales strategies. Background in international sales, with 15 years of experience of product launches.

Working in clinical and genetic diagnostics. Molecular biologist with experience in cancer genetics. Trained as an application specialist for biochemistry and immunology. Based in Skopje, R. Responsible for routine diagnostic procedures, optimization, assay development and implementation. Extensive experience in all molecular genetics processes, with a strong emphasis on NGS technology, bioinformatics, sequencing data evaluation and clinical interpretation.

Based in Berlin, Germany. Leading expert scientist in tumorcytogenetics and genetics of hematological cancer and solid tumors. Responsible for somatic variant detection and interpretation. Based in Martinsried, Germany. Biochemist and physiologist with background in teaching and research. Overseeing wet lab operations and heading sample management.

The NIPT analysis provides fetal fraction estimation and binary classification of samples into high risk or low risk for trisomy 21, 18, 13, Sex Chromosome Aneuploidies SCAs , selected microdeletions, and monogenic diseases. Multiple assays can be run simultaneously in consolidated workflows, with minimized hands-on time and re-runs, maintaining laboratory proficiency and sample handling efficiency.

Our Technology Transfer workflow delivers accurate results, while the pre- and post-deployment process initiated by Medicover Genetics, is focused on delivering excellent customer service, efficient operational management, laboratory and commercial training, and solutions for unique laboratory pain points. Variants that fall outside of the targeted regions are not intended to be detected by this assay.

In cases where two variants are identified in a gene, the test does not distinguish whether these are on one chromosome in cis or on different chromosomes in trans. Certain types of genetic abnormalities such as inversions, rearrangements, polyploidy and epigenetic effects are not covered by this test. Copy Number Variations CNVs are calculated using high quality, de-duplicated and uniquely aligned sequencing reads.

CNVs are detected for a subset of the targeted regions using a depth of sequencing coverage approach by applying GC-content normalization. Genomic regions are called as variants if their normalized depth of coverage deviates significantly from the expected normalized coverage which is estimated from a set of reference clinical samples.

The test can detect CNVs down to a few exons level resolution. The lack of disease-causing variants in the targeted genes diminishes but does not exclude the possibility of a disease associated syndrome. Although the test is highly accurate there is still a possibility for false positive or false negative results. Congenital Heart Defects Panel analyzes 80 genes and covers inherited congenital heart defects.

Aortopathy Panel analyzes 48 genes and covers aortopathy-related inherited cardiovascular disorders. Arrhythmia Panel analyzes 42 genes and covers arrhythmia-related inherited cardiovascular disorders. Cardiomyopathy Panel analyzes 98 genes and covers cardiomyopathy-related inherited cardiovascular disorders. Cardiac Comprehensive Panel analyzes genes and covers major inherited cardiovascular disorders.

TEDxUniversityofNicosia Talk: Safer than ever prenatal diagnosis In the modern era of Genetics, amniocentesis becomes irrelevant and prenatal testing is achievable with a simple and safe blood test. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network. The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

The technical storage or access that is used exclusively for statistical purposes. Patsalis was also the founder of the Akeso Fertility Center and The Cyprus School of Molecular Medicine, an academic school for graduate education, for which he served as its first Professor and Provost. Patsalis is an accomplished executive director, researcher and entrepreneur who has been bestowed with more than 30 multitude of national and international awards and distinctions for his contribution to science, innovation and business.

Board Members.